Status:
RECRUITING
Recurrence Rate of Hemorrhoidal Disease at 10 Years and More After HAL Doppler or HAL-RAR Intervention
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Hemorrhoidal Disease
Eligibility:
All Genders
18+ years
Brief Summary
The treatment of hemorrhoidal disease involves both instrumental and surgical techniques (hemorrhoidectomy and hemorrhoidopexy). In 1995, a Japanese author proposed a new treatment technique for stage...
Detailed Description
The treatment of hemorrhoidal disease involves both instrumental and surgical techniques (hemorrhoidectomy and hemorrhoidopexy). In 1995, a Japanese author proposed a new treatment technique for stage...
Eligibility Criteria
Inclusion
- Patient operated for hemorrhoidal disease for 10 or more
- Age 18 and over
- Informed patients
Exclusion
- Patient opposition
- Minor patient
Key Trial Info
Start Date :
January 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04731064
Start Date
January 6 2023
End Date
June 30 2024
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble-alpes
Grenoble, France